Harraden Group Reports 6.83% Stake in Cantor Equity
Cantor Equity Partners IV, Inc. Schedule 13G/A amendment shows that Harraden-related entities and Frederick V. Fortmiller, Jr. beneficially own 3,133,950 shares of Class A Common Stock, representing 6.83% of the class as reported.
Rhea-AI Filing Summary
Cantor Equity Partners IV, Inc. Schedule 13G/A amendment shows that Harraden-related entities and Frederick V. Fortmiller, Jr. beneficially own 3,133,950 shares of Class A Common Stock, representing 6.83% of the class as reported. The filing discloses shared voting and dispositive power over these shares.
The statement lists Harraden Circle Investments, LLC; Harraden Circle Investors GP, LP; Harraden Circle Investors GP, LLC; Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; Harraden Circle Concentrated, LP; and Mr. Fortmiller as reporting persons and describes their relationships.
Positive
- None.
Negative
- None.
Insights
Harraden group holds a 6.83% stake with shared control.
The filing records 3,133,950 shares as beneficially owned with shared voting and dispositive power, indicating coordinated ownership through funds, GP/LLC structures, and a named managing member. Ownership is cross-referenced among related entities.
Dependencies include fund structures and managerial roles; subsequent filings could clarify any voting arrangements or changes in stake. The filing date and amendment note are recorded in the cover data.
Disclosure aligns with Schedule 13G/A reporting for passive/beneficial ownership structures.
The statement identifies the reporting persons, CUSIP G1828E100, and shows shared power metrics (vote and disposition). Signatures by Mr. Fortmiller accompany the amendment dated 05/14/2026.
Qualifiers in Item 2 describe indirect beneficial ownership via GP/LLC roles; any changes to voting arrangements would require amendment filings under applicable rules.
Key Figures
Key Terms
beneficially owned regulatory
dispositive power regulatory
Schedule 13G/A regulatory
FAQ
What stake does Harraden report in Cantor Equity Partners IV (CEPF)?
Who are the reporting persons named in the 13G/A for CEPF?
What voting and dispositive powers are disclosed by Harraden in this filing?
When was the Schedule 13G/A for CEPF signed and what CUSIP is listed?
AI-generated analysis. How Rhea-AI works. Not financial advice.